Literature DB >> 18442771

Recent trends in mammography utilization in the Medicare population: is there a cause for concern?

Vijay M Rao1, David C Levin, Laurence Parker, Andrea J Frangos.   

Abstract

CONTEXT: Recent published reports have shown a decline in the mammography screening rate in women over age 40, but it is not known whether this trend is a reason for concern in the Medicare population.
OBJECTIVE: To study recent trends in mammography utilization in the Medicare population and determine how the newer digital mammography may be affecting mammography utilization. DESIGN AND
SETTING: The Centers for Medicare & Medicaid Services Physician/Supplier Procedure Summary Master Files for 1996 through 2005 were examined to determine overall trends in mammography utilization, as well as trends in screening vs diagnostic and conventional screen-film vs newer digital examinations. Medicare Limited Datasets for 2002 to 2004 were used to determine 2-year mammography and multiple imaging rates in individual patients. MAIN OUTCOME MEASURE: Mammography utilization.
RESULTS: Overall, the mammography utilization rate increased from 26,646 per 100,000 in 1996 to 39,363 per 100,000 in 2005, a 48% increase. The diagnostic mammography rate decreased by 39% (from 15,314 to 9,301), whereas the rate for screening mammography increased by 166% (from 11,332 to 30,062). Digital mammography increased from 2.2% of all mammography in 2002 to 10.4% in 2005. In both digital and film mammography, screening increased more rapidly than diagnostic mammography.
CONCLUSIONS: The utilization rate of all mammography showed a substantial 48% increase between 1996 and 2005, and an 11% increase in screening mammography was seen between 2000 and 2005. Although the increase in mammography utilization is encouraging, the 2005 rate of 39,363 per 100,000 female Medicare beneficiaries seems to be well below American Cancer Society recommendations.

Entities:  

Mesh:

Year:  2008        PMID: 18442771     DOI: 10.1016/j.jacr.2008.01.023

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  6 in total

1.  Effect of self-referral on bone mineral density testing and osteoporosis treatment.

Authors:  Amy H Warriner; Ryan C Outman; Adrianne C Feldstein; Douglas W Roblin; Jeroan J Allison; Jeffrey R Curtis; David T Redden; Mary M Rix; Brandi E Robinson; Ana G Rosales; Monika M Safford; Kenneth G Saag
Journal:  Med Care       Date:  2014-08       Impact factor: 2.983

2.  Evolution of breast cancer screening in the Medicare population: clinical and economic implications.

Authors:  Brigid K Killelea; Jessica B Long; Anees B Chagpar; Xiaomei Ma; Rong Wang; Joseph S Ross; Cary P Gross
Journal:  J Natl Cancer Inst       Date:  2014-07-16       Impact factor: 13.506

3.  Screening mammography rate and predictors following treatment for colorectal cancer.

Authors:  A Marshall McBean; Xinhua Yu; Beth A Virnig
Journal:  J Cancer Surviv       Date:  2009-02-18       Impact factor: 4.442

4.  Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S.

Authors:  Rebecca A Hubbard; Ellen S O'Meara; Louise M Henderson; Deirdre Hill; Dejana Braithwaite; Jennifer S Haas; Christoph I Lee; Brian L Sprague; Jennifer Alford-Teaster; Anna N A Tosteson; Karen J Wernli; Tracy Onega
Journal:  Prev Med       Date:  2016-05-31       Impact factor: 4.018

5.  Breast cancer after use of estrogen plus progestin in postmenopausal women.

Authors:  Rowan T Chlebowski; Lewis H Kuller; Ross L Prentice; Marcia L Stefanick; JoAnn E Manson; Margery Gass; Aaron K Aragaki; Judith K Ockene; Dorothy S Lane; Gloria E Sarto; Aleksandar Rajkovic; Robert Schenken; Susan L Hendrix; Peter M Ravdin; Thomas E Rohan; Shagufta Yasmeen; Garnet Anderson
Journal:  N Engl J Med       Date:  2009-02-05       Impact factor: 91.245

6.  What is the point: will screening mammography save my life?

Authors:  John D Keen; James E Keen
Journal:  BMC Med Inform Decis Mak       Date:  2009-04-02       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.